Sir Jim Ratcliffe has named five Manchester United players who are ‘overpaid’ after mistakes in recent transfer windows, including £86m flop Antony. Ratcliffe became minority owner of United ...

Sir Jim Ratcliffe is convinced a struggling Manchester United star will ‘come good’ eventually despite a difficult start to life in the Premier League. United are enduring one of the worst ...

JonesResearch upgraded Beam Therapeutics (BEAM) to Buy from Hold with a $34 price target Effectively assess a stock's risks and opportunities with a clear breakdown of its positive and negative ...

Scotiabank upgraded Beam Therapeutics (BEAM) to Outperform from Sector Perform with a $40 price target Effectively assess a stock's risks and opportunities with a clear breakdown of its positive ...

Beam logo CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today ...

CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

House values have risen slightly since the Reserve Bank cut interest rates, but buyers still have the upper hand in some areas.

Oklahoma has hired Senior Bowl executive director Jim Nagy as the team's new general manager, the university announced. Nagy joins the Sooners after spending the last eight years with the Senior ...

Jim Beam, the retired editor of the American Press, has covered people and politics for more than six decades. Contact him at 337-515-8871 or [email protected].

Veteran NBA agent Jim Tanner will be North Carolina basketball's general manager, UNC athletic director Bubba Cunningham announced Tuesday. Tanner's hiring comes after fourth-year coach Hubert ...

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported fourth ...

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that ...